Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126967501 | 12696750 | 1 | I | 20160616 | 20160830 | 20160830 | PER | PT-LUPIN PHARMACEUTICALS INC.-2016-02846 | LUPIN | ALMEIDA J, LOPES A, BARBOSA M. HYPERSENSITIVITY TO PROTON PUMP INHIBITORS. REVISTA PORTUGUESADE IMUNOALERGOLOGIA. 2016;24(1):31-36. | 39.00 | YR | F | Y | 0.00000 | 20160825 | OT | PT | PT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126967501 | 12696750 | 1 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNKNOWN | 0 | 400 | MG | ||||||||
| 126967501 | 12696750 | 2 | SS | ASPIRIN. | ASPIRIN | 1 | Intravenous (not otherwise specified) | UNKNOWN | 0 | ||||||||||
| 126967501 | 12696750 | 3 | PS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Intravenous (not otherwise specified) | UNKNOWN | 202384 | ||||||||||
| 126967501 | 12696750 | 4 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNKNOWN | 202384 | 20 | MG | |||||||||
| 126967501 | 12696750 | 5 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | 40 MG | UNKNOWN | 202384 | ||||||||||
| 126967501 | 12696750 | 6 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | UNKNOWN | 0 | ||||||||||
| 126967501 | 12696750 | 7 | SS | Pantoprazole | PANTOPRAZOLE SODIUM | 1 | Unknown | UNKNOWN | 0 | ||||||||||
| 126967501 | 12696750 | 8 | SS | Esomeprazole | ESOMEPRAZOLE | 1 | Unknown | UNKNOWN | 0 | ||||||||||
| 126967501 | 12696750 | 9 | SS | Rabeprazole | RABEPRAZOLE | 1 | Unknown | UNKNOWN | 78964 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126967501 | 12696750 | 1 | Product used for unknown indication |
| 126967501 | 12696750 | 2 | Influenza like illness |
| 126967501 | 12696750 | 3 | Gastrooesophageal reflux disease |
| 126967501 | 12696750 | 6 | Gastrooesophageal reflux disease |
| 126967501 | 12696750 | 7 | Gastrooesophageal reflux disease |
| 126967501 | 12696750 | 8 | Gastrooesophageal reflux disease |
| 126967501 | 12696750 | 9 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126967501 | 12696750 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126967501 | 12696750 | Angioedema | |
| 126967501 | 12696750 | Dermatitis bullous | |
| 126967501 | 12696750 | Rash generalised |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126967501 | 12696750 | 2 | 2007 | 0 | ||
| 126967501 | 12696750 | 3 | 2007 | 0 | ||
| 126967501 | 12696750 | 5 | 2010 | 0 |